Predictive markers for checkpoint-based immunotherapy in advanced non-small cell lung cancer
abstract | The aim of this study is to elucidate a novel biomarker constellation with superior predictive value for PD-1/PD-L1-targeted immunotherapy in advanced non-small cell lung cancer. |
type of project | fundamental research |
status | completed |
start of project | 2020 |
end of project | 2021 |
project manager | PD Dr. Maximilian Bösch |